Today, a Director at Chemed Corporation (CHE), Donald Saunders, sold shares of CHE for $173.1K.
Following Donald Saunders’ last CHE Sell transaction on March 22, 2019, the stock climbed by 108.5%. In addition to Donald Saunders, 3 other CHE executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Chemed Corporation’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $474 million and quarterly net profit of $50.73 million. In comparison, last year the company earned revenue of $442 million and had a net profit of $54.97 million. The company has a one-year high of $433.98 and a one-year low of $260.03. CHE’s market cap is $6.82B and the company has a P/E ratio of 35.40.
One of the top 25 analysts, according to TipRanks.com, recently recommended Buy CHE with a $440 price target.
In the last 30 days, insiders have sold $1.13M worth of CHE shares and purchased $206.4K worth of CHE shares. The insider sentiment on Chemed Corporation has been negative according to 46 insider trades in the past three months. This sentiment is slightly lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.